Imunon, Inc.
IMNN
$3.96
$0.051.15%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -43.33% | |||
| Gross Profit | -- | 43.33% | |||
| SG&A Expenses | 2.32% | -22.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 25.58% | -33.23% | |||
| Operating Income | -25.58% | 33.23% | |||
| Income Before Tax | -25.12% | 33.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -25.12% | 33.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.12% | 33.20% | |||
| EBIT | -25.58% | 33.23% | |||
| EBITDA | -26.28% | 33.97% | |||
| EPS Basic | 37.57% | 49.24% | |||
| Normalized Basic EPS | 37.57% | 49.24% | |||
| EPS Diluted | 37.57% | 49.24% | |||
| Normalized Diluted EPS | 37.57% | 49.24% | |||
| Average Basic Shares Outstanding | 100.42% | 31.60% | |||
| Average Diluted Shares Outstanding | 100.42% | 31.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||